The Art of
Licensing 		The Art of
Development 		The Art of
Access 		The Art of
Manufacturing 		The Art of
Partnership
Home > The Art of Access > Our products > Cancer Supportive Care > ZP1846
ZP1846
  • Originator: Zealand Pharma A/S – Denmark.
  • ZP1846 is a 39 amino acids polypeptide, novel Glucagon-like Peptide-2 (GLP-2) analogue, exerting trophic effects on the intestinal mucosa which is under development for the management of chemotherapy-induced diarrhea.
  • A 39 amino acids polypeptide
    H-HGEGSFSSELSTILDALAARDFIAWLIATKITDKKKKKK-NH2
  • Development status: phase 1b.
    •
     
    Home
    Legal Statement
    News
    Contacts
    Sitemap
    Document Central
    Jobs
    Helsinn′s Board of Directors and Top Management
    Printer Friendly
    Copyright © Helsinn Group - Legal Statement
    Last Update: 01.09.2010
    About Helsinn Our Products Our Partners